The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Cancers (Basel) · 2021 · PMC8471511 · PMID 34572883

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantp = 0.06so close (0.05 < p ≤ 0.1)

When compared to the nIBC cohort, this decrease was significantly higher in TN IBC ( p = 0.007), borderline significant ( p = 0.06) in the HR+ IBC and not significant in HER2+ IBC ( p = 0.37).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.